Rezolute RZLT
NASDAQ RZLT
$3.86 0.00 (-0.13%)
At close: Oct 23, 2026 · 4:00 PM EDT

Rezolute (RZLT) Amortization of Deferred Charges (2012 - 2022)

Updated

Analysis

Rezolute (RZLT) Amortization of Deferred Charges (2012 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Rezolute 401.60 Mn -111.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 2.81 Mn
Mar 31, 2022 -108,000.00
Dec 31, 2021 -107,000.00
Sep 30, 2021 -104,000.00
Mar 31, 2019 472,000.00
Dec 31, 2018 878,000.00
Sep 30, 2018 703,000.00
Jun 30, 2018 -473,303.00
Mar 31, 2018 -31,697.00
Mar 31, 2014 2.94 Mn
Dec 31, 2013 342,128.00
Sep 30, 2013 75,508.00
Jun 30, 2013 90,585.00
Mar 31, 2013 101,082.00
Dec 31, 2012 42,643.00
Sep 30, 2012 44,786.00
API Access

Rezolute Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=RZLT&period=max&api_key=YOUR_API_KEY